Empagliflozin: A sodium–glucose cotransporter 2 inhibitor for treatment of type 2 diabetes-Reference-Cited by-同舟云学术

Empagliflozin: A sodium–glucose cotransporter 2 inhibitor for treatment of type 2 diabetes

Published:2015-11-15 Issue:22 Volume:72 Page:1943-1954
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Dixit Divisha¹,Yoon Youngmin²,Volino Lucio R.³,Mansukhani Rupal Patel⁴

Affiliation:

1. Pharmaceutical Fellowship Program, Ernest Mario School of Pharmacy at Rutgers, State University of New Jersey (SUNJ), Piscataway; at the time of writing she was a Pharm.D. student, Ernest Mario School of Pharmacy at Rutgers, SUNJ

2. Ernest Mario School of Pharmacy at Rutgers, SUNJ

3. Ernest Mario School of Pharmacy at Rutgers, SUNJ, and Clinical Pharmacist, Great Atlantic and Pacific Tea Company, Kenilworth, NJ

4. Ernest Mario School of Pharmacy at Rutgers, SUNJ, and Clinical Pharmacist, Transitions of Care, Morristown Medical Center, Morristown, NJ

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/72/22/1943/28318698/ajhp1943.pdf

Reference46 articles.

1. Standards of medical care in diabetes—2014;American Diabetes Association;Diabetes Care,2014

2. Renal sodium-glucose transport: role in diabetes mellitus and potential clinical implications;Bakris;Kidney Int,2009

3. SGLT2 inhibitors in the treatment of type 2 diabetes;Hasan;Diabetes Res Clin Pract,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, Isolation, Characterization and Suppression of Impurities during Optimization of Empagliflozin (Jardiance);Organic Preparations and Procedures International;2022-02-23

2. RP-HPLC method development for simultaneous estimation of empagliflozin, pioglitazone, and metformin in bulk and tablet dosage forms;Acta Poloniae Pharmaceutica - Drug Research;2021-08-27

3. Efficacy and safety of sotagliflozin adjuvant therapy for type 1 diabetes mellitus;Medicine;2020-08-14

4. CE: Type 2 Diabetes: A Pharmacologic Update;AJN, American Journal of Nursing;2019-03